Benutzer-Werkzeuge

Webseiten-Werkzeuge


asarum_canadense_l

Unterschiede

Hier werden die Unterschiede zwischen zwei Versionen angezeigt.

Link zu dieser Vergleichsansicht

Beide Seiten der vorigen Revision Vorhergehende Überarbeitung
asarum_canadense_l [2017/10/18 15:07]
andreas
asarum_canadense_l [2022/08/27 10:42] (aktuell)
andreas
Zeile 16: Zeile 16:
 [Aromas From Quebec. II. Composition of the Essential Oil of the Rhizomes and Roots of Asarum canadense L., Bélanger, A., Collin, G., Garneau, F.X., Gagnon, H., Pichette, A., Journal of Essential Oil Research, 22(2), 2010, 164-169] [Aromas From Quebec. II. Composition of the Essential Oil of the Rhizomes and Roots of Asarum canadense L., Bélanger, A., Collin, G., Garneau, F.X., Gagnon, H., Pichette, A., Journal of Essential Oil Research, 22(2), 2010, 164-169]
  
-In 2010, the use of all plants belonging to the Asarum species in drugs was banned in Germany by decree of the Federal Institute for Drugs and Medical Devices (BfArM). The cause of this was the detection of aristolochic acid I in homeopathic mother tinctures of Asarum europaeum with approximately 0.044 to 0.13 ppm, and of Asarum canadense with approximately 127.4g/kg (about 0.13 ppm). \\+In 2010, the use of all plants belonging to the Asarum species in drugs was banned in Germany by decree of the Federal Institute for Drugs and Medical Devices (BfArM). The cause of this was the detection of aristolochic acid I in homeopathic mother tinctures of Asarum europaeum with approximately 44-128µg/kg, and of Asarum canadense with approximately 127µg/kg. \\
 [[http://www.bfarm.de/SharedDocs/Downloads/DE/Arzneimittel/Pharmakovigilanz/Risikoinformationen/RisikoBewVerf/a-f/aristolochia_bescheid.pdf?__blob=publicationFile&v=2]] [[http://www.bfarm.de/SharedDocs/Downloads/DE/Arzneimittel/Pharmakovigilanz/Risikoinformationen/RisikoBewVerf/a-f/aristolochia_bescheid.pdf?__blob=publicationFile&v=2]]
  
asarum_canadense_l.1508332058.txt.gz · Zuletzt geändert: 2017/10/18 15:07 von andreas